Logo

OpiCalc

FavoritesSpecialtiesDrugsGuidelinesMost Used

All Specialties

OpiCalc Logo
FavoritesSpecialtiesDrugsGuidelinesMost Used
FavesSpecsDrugsGuidesTop
ALBI Grade (Liver)ASTCT GradingATA Thyroid RiskBCLC 2022 Staging (HCC)BSA (Mosteller)CLL-IPICML ELTS ScoreCNS-IPICTCAE v5.0Calvert FormulaDIPSS-Plus (Myelofibrosis)Deauville ScoreEAU NMIBC RiskECOG Performance StatusELN 2022 Risk (AML)ELN CML MilestonesFIGO 2021 (Ovarian)FIGO 2023 (Endometrial)FLIPI-2Fleischner 2017 GuidelinesFong Clinical Risk ScoreHCT-CI (Sorror Score)HPV/p16 OropharynxIGCCCG Risk (Testicular)IMDC (Heng) CriteriaIMWG Myeloma FrailtyIPSS-M (Molecular MDS)ISUP Grade GroupsKarnofsky Status (KPS)Khorana ScoreLugano ClassificationLung-RADS v2022MIPI-b (Biological)MRD Assessment FrameworkMSI/MMR InterpretationMayo 20/2/20 (SMM)NCCN Prostate RiskNCCN-IPI (DLBCL)NSCLC GPAOncotype DX RecurrenceOpioid EquianalgesicPD-L1 TPS InterpretationPERCIST 2.0PREDICT v3.0Platinum-Free IntervalR2-ISS (Revised 2)RANO 2.0RCB (Residual Cancer Burden)RECIST 1.1ROMA ScoreSAVER ScoreSINS ScoreSLiM-CRAB CriteriaSedlis/Peters CriteriaTNM 8th (Colorectal)TNM 8th Ed (Prognostic)TNM 9th (Nasopharynx)TNM 9th Ed (NSCLC)TNM 9th Ed (SCLC)Tyrer-Cuzick (IBIS v8)WHO 2021 CNS Class.WHO 2022 / ICC 2022 AMLZ0011 EligibilityiRECISTiwCLL 2018 ResponsemRECIST (HCC)mRENAL ScoremrTRG (Rectal MRI)
OpiCalc Logo

OpiCalc

Easy, fast, and private medical tools for clinicians. Always free.

No Login Required
Ready for the Bedside

Resources

About UsEditorial PolicyMedical DisclaimerPrivacy PolicyTerms of UseCookie Policy

Support

Contact Us

Clinical Notice:OpiCalc is not a substitute for professional clinical judgment. Always verify dosages and guidelines.

OpiCalc © 2018-2026

•

All Rights Reserved

Recent Journal Updates

DiabetologiaJun 6, 2026
SARS-CoV-2 infection and COVID-19 vaccination and the risk for new-onset type 1 diabetes: a register-based population study in Sweden

Clinical Context

We think this might be relevant to the clinical guidance for Platinum-Free Interval (PFI).

Drug SafetyJun 2, 2026
Gabapentin and Pregabalin Use in First Trimester of Pregnancy and Risk of Specific Congenital Anomalies: An IMI ConcePTION European Case-Malformed Control Study

Clinical Context

We think this might be relevant to the clinical guidance for Platinum-Free Interval (PFI).

Drug SafetyMay 12, 2026
Theoretical Framework and Key Considerations for Time-to-Onset Analysis in Spontaneous Reporting Systems

Clinical Context

We think this might be relevant to the clinical guidance for Platinum-Free Interval (PFI).

Platinum-Free Interval

PFIPlatinum-Free Interval Assessment

Clinical Timeline

Months

Historical Context

The 6-month threshold remains the standard for clinical trial stratification and therapy selection. However, modern oncology recognizes PFI as a continuum, where longer intervals correlate with higher response rates to subsequent platinum-based therapy.

Therapeutic Category

Platinum-Sensitive

Management Strategy

Sensitive recurrence (> 6-12 months). Re-challenge with platinum-based doublet is the standard of care.

Guidelines & Evidence

Verified

Last Review: 2026

When to Use

Clinical Use

Applied exclusively when a patient with ovarian cancer relapses after completing frontline platinum-based chemotherapy.
Dichotomizes patients to determine the backbone of the second-line chemotherapy regimen.
Determines eligibility for PARP inhibitor maintenance in the relapsed setting.

Related Scores in Practice

In clinical practice, this assessment is frequently evaluated alongside other validated measures. Depending on the patient's presentation and specific diagnostic requirements, you may also need to utilize the FIGO 2021 (Ovarian) or the ROMA Score to formulate a comprehensive care plan.

Last Comprehensive Review: 2026

Related Oncology Tools

FIGO 2021
ROMA Score
R2-ISS
CLL-IPI
SINS Score
WHO 2022 / ICC 2022 AML
Opioid Equianalgesic
DIPSS-Plus
NCCN Prostate Risk
FIGO 2023
Oncology CalculatorsInternal Medicine CalculatorsEmergency Medicine Calculators
Have feedback about this calculator?Let us know.